Real-world use of systemic therapy in elderly patients with malignant pleural mesothelioma (MPM)

被引：0
|
作者：
Cedres, S. [1 ,2 ]
Assaf, J. D. [3 ]
Iranzo, P. [1 ,2 ]
Callejo, A. [1 ,2 ]
Pardo, N. [1 ,2 ]
Navarro, A. [1 ,2 ]
Martinez-Marti, A. [1 ,2 ]
Rodriguez, G. [1 ,2 ]
Monton, V. [1 ,2 ]
Gonzalo, J. [1 ]
Miquel, J. M. [1 ]
Pedrola, A. [1 ]
Dienstmann, R. [4 ]
Felip, E. [5 ]
机构：
[1] Vall dHebron Inst Oncol, Med Oncol, Barcelona, Spain
[2] Univ Hosp, Barcelona, Spain
[3] Vall dHebron Univ Hosp, Oncol, Barcelona, Spain
[4] Vall dHebron Univ Hosp, Oncol Data Sci, Barcelona, Spain
[5] Vall dHebron Univ Hosp, Lung Canc Unit, Med Oncol Serv, Barcelona, Spain
来源：
ANNALS OF ONCOLOGY | 2019年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1853P
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Weekly Epirubicin as palliative treatment in patients with malignant pleural mesothelioma (MPM)
    Belloni, P.
    Cozzi, C.
    Zannier, F.
    Della Torre, S.
    Toniolo, D.
    Corradini, G. M.
    Candido, P.
    Bollina, R.
    [J]. ANNALS OF ONCOLOGY, 2016, 27
  • [42] Chest Dynamics in Malignant Pleural Mesothelioma (MPM) Patients Using Real Time Respiratory Motion MRI
    Saleh, R. S.
    Cameron, R.
    Lohan, D. G.
    Moghaddam, A. N.
    Mahidhara, R.
    Goldin, J.
    Finn, J. P.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179
  • [43] Mesothelin is a biomarker of tumor aggressiveness and therapy response in malignant pleural mesothelioma (MPM)
    Servais, Elliot L.
    Colovos, Christos
    Suzuki, Kei
    Velez, Marissa
    Rodriguez, Luis
    Sima, Camelia
    Rusch, Valerie W.
    Sadelain, Michel
    Adusumilli, Prasad S.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2010, 211 (03) : S36 - S36
  • [44] The value of volumetric measurement of malignant pleural mesothelioma (MPM) to assess the therapy response
    Tutic, Michaela
    Frauenfelder, Thomas
    Goetti, Robert
    Schramm, Alexandra
    Weder, Walter
    Marincek, Borut
    Stahel, Rolf
    Opitz, Isabelle
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S461 - S461
  • [45] Novel systemic therapy against malignant pleural mesothelioma
    Mancuso, Michael R.
    Neal, Joel W.
    [J]. TRANSLATIONAL LUNG CANCER RESEARCH, 2017, 6 (03) : 295 - 314
  • [46] THE VALUE OF VOLUMETRIC MEASUREMENT OF MALIGNANT PLEURAL MESOTHELIOMA (MPM) TO ASSESS THE THERAPY RESPONSE
    Tutic, M.
    Frauenfelder, T.
    Schramm, A.
    Goetti, R. P.
    Weder, W.
    Marincek, B.
    Opitz, I.
    [J]. LUNG CANCER, 2009, 64 : S63 - S63
  • [47] Combined modality treatment for malignant pleural mesothelioma (MPM)
    Nafteux, Ph.
    Nackaerts, K.
    Lievens, Y.
    Vansteenkiste, J.
    Demedts, M.
    Van den Bogaert, W.
    Lerut, T.
    [J]. LUNG CANCER, 2006, 52 : S26 - S26
  • [48] Combined modality treatment for Malignant Pleural Mesothelioma (MPM)
    Nackaerts, Kristiaan
    Nafteux, Philippe
    Lievens, Yolande
    Vansteenkiste, Johan
    Demedts, Maurits
    van den Bogaert, Walter
    Lerut, Toni
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2007, 2 (08) : S429 - S429
  • [49] Molecular prognostic markers in Malignant Pleural Mesothelioma (MPM)
    Bahnassy, Abeer A.
    Gaafar, Rabab M.
    Zekri, Abdel-Rahman N.
    Abdelrahman, Abdelrahman M.
    Aboulkassem, Fatma A.
    Elsherif, Ghada M.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S757 - S757
  • [50] Pemetrexed and carboplatin in the treatment of malignant pleural mesothelioma (MPM)
    Papi, M.
    Genestreti, G.
    Tassinari, D.
    Tamburini, E.
    Nicoletti, S.
    Nicolini, M.
    Fabbri, P.
    Fabbri, P.
    Santo, A.
    Pasquini, E.
    Ravaioli, A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
12345